InvestorsHub Logo
Followers 42
Posts 12464
Boards Moderated 0
Alias Born 11/18/2016

Re: dafreaks post# 70879

Monday, 06/11/2018 2:05:48 PM

Monday, June 11, 2018 2:05:48 PM

Post# of 108192
The reasoning on Amgen's part (and often the baby bio's part) is that they do not want the financial terms of one development deal to effect the negotiation of deals with other companies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News